Skip to main content
Radiology Case Reports logoLink to Radiology Case Reports
. 2021 Aug 26;16(11):3152–3156. doi: 10.1016/j.radcr.2021.07.059

A broken lead to an open heart: implantable cardioverter defibrillator vegetations with lead fracture

George Horani a,, Kevin Hosein b, Rahul Kumar b, Fayez Shamoon b
PMCID: PMC8403715  PMID: 34484509

Abstract

Implantable cardiac devices are widely used devices that serve several purposes. Complications from devices are not uncommon and include localized or systemic infections, device-related endocarditis, and device malfunction leading to serious outcomes, including death. Another possible complication that has been reported in the literature is thrombus formation on the device leads. We present a rare case of large thrombi forming on the leads of an implantable cardioverter defibrillator leading to lead fracture and device malfunction. After the device alerted for malfunction, the patient underwent a transesophageal echocardiogram which demonstrated masses on the right atrium and ventricle. He subsequently had a right atrial exploration and lead extraction which revealed large thrombi on the leads which histologically were identified as sterile vegetations.

Keywords: Implantable cardioverter defibrillator, Thrombus, Lead fracture

Introduction

Implantable cardioverter defibrillators (ICDs) are devices that serve several purposes, mainly for the identification and treatment of life-threatening arrhythmias such as ventricular tachycardia or fibrillation which can lead to sudden cardiac death. Short and long-term complications from ICD placement include infection, bleeding, device malfunction, lead fracture, and rarely, death due to pulseless electrical activity [1]. Device-related infective endocarditis has been a well-known phenomenon in patients with ICDs, and treatment involves antibiotics and hardware removal. However, the growth of sterile vegetations on cardiac device leads is a relatively rare but previously described event. Depending on the size of the thrombus, it is usually treated with anticoagulation or thrombolysis [2,3]. Limited data exists on thrombi-related lead fracture.

Case report

The patient is a 40-year-old male with a medical history significant for non-ischemic cardiomyopathy with severely reduced left ventricular ejection fraction of 20%-25% requiring a biventricular implantable cardioverter defibrillator (ICD) in 2017 who presented to the hospital for replacement of an ICD lead after the device alerted for a fractured coil. Chest x-ray in posteroanterior view showed the ICD in situ with a right lung base opacity/density which may represent a mass (Fig. 1). The patient underwent a transesophageal echocardiogram (TEE) prior to the lead extraction which demonstrated extensive mobile masses adhering to the right atrium and right ventricle, each measuring approximately 2 cm in size and concerning for thrombi or vegetations (Fig. 2-3). The procedure was aborted, and the patient was referred to cardiothoracic surgery for an open extraction and evaluation of the lead and masses. At that time, the patient was afebrile with a temperature of 36.4 degrees Celsius, heart rate of 79 beats per minute, and a blood pressure of 165/94 mmHg; the rest of the physical exam was unremarkable, including cardiac exam which did not reveal any murmurs or gallops. His complete blood count showed only thrombocytopenia with platelet count of 79,000/mm3 (140-440K/mm3) and a normal white blood cell count of 10.5 × 10^3/mm3 (4.5 – 11.0 × 10^3/mm3). He was not on any antiplatelet or anticoagulant agents prior. Broad spectrum antibiotics Vancomycin and Piperacillin-Tazobactam were started, and blood cultures were obtained. They subsequently grew Staphylococcus epidermidis in only one bottle. This was attributed to skin contamination and the antibiotics were discontinued.

Fig. 1.

Fig 1

Chest x-ray in posteroanterior view showing the ICD in place and the right lung base opacity.

Fig. 2.

Fig 2

TEE mid-esophageal 4-chamber view demonstrating large mass in the right atrium.

Fig. 3.

Fig 3

TEE bicaval view demonstrating mass adherent to ICD lead.

The patient subsequently had right atrial exploration by the cardiothoracic surgery team with removal of the ICD leads and generator, which revealed soft vegetative tissue overlying the wires (Fig. 4). Cultures from the cardiac tissue were obtained and were negative for any bacterial growth. The pathology of the vegetative tissue was found to be a sterile fibrinous vegetation with prominent calcification. The patient was extubated after the procedure and was discharged home a few days later with a wearable cardioverter defibrillator.

Fig. 4.

Fig 4

Intraoperative photo demonstrating explanted ICD lead with adherent large mass.

Discussion

An ICD is a device that helps identify and treat arrhythmias, mostly ventricular arrhythmias. It consists of 3 components – a generator which identifies the rhythms and need for cardioversion or defibrillation, the leads which conduct the electric activity between the device and myocardium, and the shocking coil which delivers the charge.[1] There are several indications for ICD placement, for the goal of both primary and secondary prevention of sudden cardiac death from life-threatening arrhythmias, such as ventricular fibrillation or ventricular tachycardia.[4] Complications resulting from ICD placements are rare. Overall, the prevalence of complications is up to 4% and can be divided into short-term and long-term. Short-term complications can be related to access (such as bleeding, vein thrombosis, or pneumothorax), the pocket (pain or hematoma), device-related infection (1%-2%), and very rarely, pulseless electrical activity and death (<1%). Long-term complications (up to 4%) include device-related pain, lead fracture, inappropriate shock delivery, phantom shock, device erosion, device infection, and immunologic rejection.[1,5] Device infection can have different presentations, including local pain, erythema, tenderness, and swelling, fever without local changes, bacteremia without local changes, or a lead thrombus or vegetation seen on echocardiography.[6] Cardiac device-related infective endocarditis has been described in the literature, and management involves both removal of the hardware and treatment with antibiotics.[7,8]

Although rare, sterile thrombus formation on implantable cardiac devices is not negligible and the incidence has been reported to be around 1.4% on transthoracic echocardiography.[2,3] The proposed mechanism of thrombus formation is altered blood flow and platelet aggregation around the foreign body leading to fibrin deposition. The treatment for asymptomatic thrombosis varies based on individual circumstance. Small thrombi may be treated with anticoagulation while larger ones may require thrombolysis.[2] In our case, the thrombi were large and caused lead fracture, requiring total extraction of the device and leads.

In this case report, our aim is to highlight the rare occurrence of lead fracture from a sterile vegetative growth causing device malfunction. Given its low incidence of detection on TTE, we do not recommend routine cardiac ultrasound to assess for vegetations in the absence of any clinical or otherwise device malfunction signs and symptoms. Rather, we suggest maintaining a high clinical suspicion and timely intervention with TEE and possible surgery to restore ICD function can be lifesaving.

Footnotes

Acknowledgements: None

Competing Interests: None

Patient consent: Written informed consent for publication of this case was obtained from the patient himself.

References

  • 1.Iqbal A.M., Butt N., Jamal S.F. StatPearls [Internet]. Treasure Island (FL) StatPearls Publishing; Jan 2021. Automatic internal cardiac defibrillator. [updated 2020 Jun 3] [PubMed] [Google Scholar]
  • 2.Monzo L., Silvetti E., Maresca L., Della Bona R., De Ruvo E., Calò L. A walking thrombus. Acta Cardiol Sin. 2020;36(1):81–83. doi: 10.6515/ACS.202001_36(1).20190823A. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Buttigieg J., Asciak R., Azzopardi C.M. Pacemaker lead-associated thrombosis in cardiac resynchronisation therapy. BMJ Case Rep. 2015 doi: 10.1136/bcr-2015-210314. 2015:bcr2015210314. Published 2015 Jul 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kusumoto F.M., Calkins H., Boehmer J., Buxton A.E., Chung M.K., Gold M.R. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014;130(1):94–125. doi: 10.1161/CIR.0000000000000056. [DOI] [PubMed] [Google Scholar]
  • 5.Ezzat V.A., Lee V., Ahsan S. A systematic review of ICD complications in randomised controlled trials versus registries: is our 'real-world' data an underestimation? Open Heart. 2015;2(1) doi: 10.1136/openhrt-2014-000198. Published 2015 Feb 17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.DeSimone D.C., Sohail M.R. Approach to diagnosis of cardiovascular implantable-electronic-device infection. J Clin Microbiol. 2018;56(7) doi: 10.1128/JCM.01683-17. e01683-17. Published 2018 Jun 25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sohail M.R., Uslan D.Z., Khan A.H. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46–53. doi: 10.4065/83.1.46. [DOI] [PubMed] [Google Scholar]
  • 8.Edelstein S., Yahalom M. Cardiac device-related endocarditis: Epidemiology, pathogenesis, diagnosis and treatment - a review. Int J Angiol. 2009;18(4):167–172. doi: 10.1055/s-0031-1278347. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Radiology Case Reports are provided here courtesy of Elsevier

RESOURCES